The US Food and Drug Administration (FDA) said it has no plans to recall metformin, a diabetes drug, after it failed to show any evidence of contamination with a carcinogen called N-nitrosodimethylamine (NDMA). The FDA said it would continue monitoring NDMA in metformin medications.
The US Department of Veterans Affairs collaborated with a startup company called Virta Health to focus their attention on the company’s claim to reverse type 2 diabetes with the keto diet. However, some experts have raised concerns about the company’s claim to reverse diabetes with the keto diet.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, could play a key role in reducing the risk of gout in people with type 2 diabetes and other metabolic conditions. Researchers found that these diabetes drugs could get rid of excess uric acid from the body.
A new study, published in journal Cell Metabolism, has been able to explain the cause of type 2 diabetes and how it can be reversed. The study found that excess liver fat could be the cause of type 2 diabetes and it can be reversed by implementing lifestyle interventions.
A new study has found that children who have type 1 diabetes are more likely to have poor brain function. The study also found that type 1 diabetic children who have the condition for a longer duration had pronounced changes in their brain function, suggesting that the condition may get worse.
A new study has found that most people in the United States have been turning to the black market for donating, sharing, and trading diabetes medications and blood-test supplies. The US healthcare system has been failing to meet the needs of patients to manage diabetes so they are relying on the black market, which is illegal.
A new study, published in PNAS, has found that a certain type of calcium channel that is found in the insulin-secreting beta cells plays an important role in the development of diabetes. Researchers believe that blocking this calcium channel could help in developing new strategies for treating diabetes.